UmarFarooqMDMS, MBA, FASN

Nephrology • Hershey, PA

Acute Renal Failure, Chronic Renal Failure & Dialysis, Glomerular Disease, Hypertension

Associate Chief Medical Officer | Academic Nephrologist | Associate Professor | Clinical Trials | Educator

Join to view full profile

Dr. Farooq is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Farooq's full profile

Already have an account?

Office
500 University Dr
Hershey, PA 17033
Phone+1 800-243-1455

Summary

Dr. Umar Farooq is a nephrologist in Hershey, PA and is affiliated with Penn State Milton S. Hershey Medical Center. He received his medical degree from King Edward Medical University and has been in practice 16 years. He specializes in chronic renal failure & dialysis, glomerular disease, hypertension, and kidney & pancreas transplantation and is experienced in hypertension, acute renal failure, transplant nephrology, chronic renal failure, and anemia of chronic kidney disease.

Mastering the Business of Health Care - Penn State Smeal Magazine

How two physicians and longtime friends turned to the Penn State Online MBA to enhance their leadership skills | By Jim Carlson

Education & Training

Penn State University College of MedicineMS, Public Health Sciences, 2009 - 2011
Penn State Milton S Hershey Medical CenterFellowship, Nephrology, 2008 - 2010
UPMC Medical EducationResidency, Internal Medicine, 2005 - 2008
King Edward Medical UniversityClass of 2001

Certifications & Licensure

PA State Medical License 2005 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
American society of hypertensionHypertension Specialist

Clinical Trials

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease Start of enrollment: 2015 Sep 17
Completed
Phase 3
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease Start of enrollment: 2015 Sep 17
Completed
Phase 3
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation Start of enrollment: 2016 Dec 01
Completed
Phase 4
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy Start of enrollment: 2021 Jun 25
Active, not recruiting
Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function Start of enrollment: 2024 Apr 12
Recruiting
Phase 3
TARGET BP I Clinical Trial Start of enrollment: 2019 Jul 22
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Primary hyperaldosteronism secondary to right adrenal hyperplasia with non-functioning left adrenal adenoma elucidated by adrenal vein sampling: A case report with in-...
Adam Tuchinsky, Sundus Sardar, Abdel-Rauof M Akkari, Ahmad Samir Matarneh, Gia Susan John
Clinical Case Reports. 2024-10-01
Prospective Comparison of Urinary Measured Creatinine Clearance With eGFR and Cystatin C Based Cis-eGFR, Including Kinetic eGFR in the Immediate Post-transplant Period...
Ashokkumar Jain, Umar Farooq, Nasrollah Ghahramani, Deborah Daoud, Eileen Swartz
Transplantation Proceedings. 2024-07-08
1 citations
Plasmapheresis Decreases Belatacept Exposure: Requires Consideration for Dose and Frequency Adjustments.
Ashokkumar Jain, Ruichao Xu, Raman Venkataramanan, Umar Farooq, Fauzia Butt
Transplantation. 2021-10-01